NORDH — Nordhealth AS Cashflow Statement
0.000.00%
Last trade - 00:00- NOK2.05bn
- NOK1.89bn
- €50.84m
Annual cashflow statement for Nordhealth AS, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | NAS | NAS | NAS | NAS | NAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.65 | -14.1 | -10.8 | -6.64 | -12.3 |
| Depreciation | |||||
| Non-Cash Items | 0.869 | 0.816 | 0.698 | -1.26 | 2.12 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5.11 | -1.69 | -5.25 | -1.07 | -0.392 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 5.57 | -6.3 | -5.22 | 1.85 | 0.719 |
| Capital Expenditures | -3.38 | -6.8 | -5.72 | -5.02 | -5.09 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -88.8 | 4.71 | 3.1 | 2.25 | 5.5 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -92.1 | -2.09 | -2.63 | -2.77 | 0.402 |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 109 | -2.08 | -2.35 | 0 | -0.885 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 22.4 | -10.7 | -10.5 | -0.957 | 0.265 |